A detailed history of Lpl Financial LLC transactions in Scynexis Inc stock. As of the latest transaction made, Lpl Financial LLC holds 62,380 shares of SCYX stock, worth $69,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,380
Previous 75,530 17.41%
Holding current value
$69,241
Previous $112,000 36.61%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$1.0 - $1.53 $13,150 - $20,119
-13,150 Reduced 17.41%
62,380 $71,000
Q3 2024

Nov 08, 2024

BUY
$1.27 - $2.23 $3,873 - $6,801
3,050 Added 4.21%
75,530 $112,000
Q2 2024

Aug 07, 2024

BUY
$1.4 - $2.77 $101,472 - $200,769
72,480 New
72,480 $144,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $36.2M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.